As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus's threat to human ...

As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus's threat to human ...

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Older adults who were exposed to seasonal flu viruses that circulated prior to 1968 are more likely to have some protection against H5N1, and children would benefit more from H5N1 vaccines.

Here are four more updates: Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at ...

The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

As the measles outbreak in the U.S. spreads, experts fear that other preventable diseases, including polio, rubella, and mumps, could return. Here’s what you can do to stay safe.

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...